Action to Control Cardiovascular Risk in Diabetes (ACCORD)

Completed · Phase 3 · Has a placebo group

Conditions studied: Atherosclerosis, Cardiovascular Diseases, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Type 2, Diabetes Mellitus, Coronary Disease

In brief

The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.

Key facts

Study ID
NCT00000620
Run by
National Heart, Lung, and Blood Institute (NHLBI)
People needed
10251
Starts
1999-09-01
Expected to finish
2012-12-01
Last updated by the study team
2016-11-22

Who can join

Age: 40 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.